Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression
- PMID: 21909787
- DOI: 10.1007/s13277-011-0232-z
Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression
Abstract
N-myc downstream-regulated gene-1 (NDRG1) has been identified as a protein involved in the differentiation of epithelial cells. As a newly metastasis suppressor gene, whether it contributes to carcinogenesis of breast cancer is still unknown. This study aimed to clarify the possible role of NDRG1 for breast cancer carcinogenesis, and further to investigate its clinicopathological significance in invasive breast cancer. We examined the expression of NDRG1 in normal epithelium of breast (n = 35), usual ductal hyperplasia (n = 22), atypical ductal hyperplasia (n = 33), atypical lobular hyperplasia (n = 8), ductal carcinoma in situ (n = 16), lobular carcinoma in situ (n = 6), invasive ductal carcinoma (n = 50), and invasive lobular carcinoma (n = 45) by immunohistochemistry and analyzed the correlation between NDRG expression and clinicopathological features of invasive breast cancer. Western blot analysis was carried out to investigate the expression of NDRG1 in 20 invasive ductal breast cancer and the paired non-tumor portion of the same case. NDRG1 expression in invasive breast cancer (70/95, 73.7%) was higher than that in noninvasive breast lesions (29/85, 34.1%; p < 0.05) which was higher than that in normal breast epithelium (5/35, 14.3%; p < 0.05). Statistical analysis revealed a significant correlation between NDRG1 expression with tumor stage in invasive breast cancer, and its expression in invasive ductal carcinoma is significantly higher than invasive lobular carcinoma (p < 0.05). It was not associated with age, menopausal status, tumor size, and lymph node metastasis. NDRG1 protein levels were significantly higher in invasive ductal breast cancer compared to the paired non-tumor portion of the same case by Western blot analysis (p < 0.05). Increased NDRG-1 expression is associated with breast atypia-to-carcinoma progression. NDRG1 expression might participate in the carcinogenesis and progression of invasive breast cancer. These findings provide further evidence that NDRG1 may serve as an important biomarker for invasive breast cancer.
Similar articles
-
Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma.Tumour Biol. 2014 Nov;35(11):11337-43. doi: 10.1007/s13277-014-2473-0. Epub 2014 Aug 14. Tumour Biol. 2014. PMID: 25119601
-
Expression of c-kit in common benign and malignant breast lesions.Tumori. 2010 Nov-Dec;96(6):978-84. Tumori. 2010. PMID: 21388062
-
High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.Am J Surg Pathol. 2007 Mar;31(3):417-26. doi: 10.1097/01.pas.0000213368.41251.b9. Am J Surg Pathol. 2007. PMID: 17325484
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Use of immunohistochemistry in the diagnosis of problematic breast lesions.J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13. J Clin Pathol. 2013. PMID: 23486609 Review.
Cited by
-
NDRG1 in Cancer: A Suppressor, Promoter, or Both?Cancers (Basel). 2022 Nov 22;14(23):5739. doi: 10.3390/cancers14235739. Cancers (Basel). 2022. PMID: 36497221 Free PMC article. Review.
-
NDRGs in Breast Cancer: A Review and In Silico Analysis.Cancers (Basel). 2024 Mar 29;16(7):1342. doi: 10.3390/cancers16071342. Cancers (Basel). 2024. PMID: 38611020 Free PMC article. Review.
-
MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.Cancer Sci. 2019 Jan;110(1):135-146. doi: 10.1111/cas.13863. Epub 2018 Dec 21. Cancer Sci. 2019. PMID: 30407715 Free PMC article.
-
DDEFL1 correlated with Rho GTPases activity in breast cancer.Oncotarget. 2017 Oct 26;8(68):112487-112497. doi: 10.18632/oncotarget.22095. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348842 Free PMC article.
-
N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review).Oncol Lett. 2013 Dec;6(6):1539-1542. doi: 10.3892/ol.2013.1636. Epub 2013 Oct 18. Oncol Lett. 2013. PMID: 24260043 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials